Chamber Disinfection Devices Using Nebulized Fluid And Plasma
20230077709 · 2023-03-16
Inventors
Cpc classification
A61L2202/14
HUMAN NECESSITIES
A61L2/24
HUMAN NECESSITIES
A61L2202/15
HUMAN NECESSITIES
A61L2202/11
HUMAN NECESSITIES
International classification
Abstract
Disinfection devices are provided which include an enclosure comprising an interior cavity, a closable loading port for providing access to the interior cavity, a cold plasma generator, a fan, a nebulizer and optionally a heating element to heat the interior cavity. In some cases, the cold plasma generator, the fan, and the nebulizer are arranged in the disinfection device such that plasma species generated by the cold plasma generator are routed to an area to which droplets formed by the nebulizer are discharged and the interior cavity is exposed to a mixture of the droplets and the plasma species. In some additional or alternative cases, the disinfection device includes an electronic control system comprising a processor and a storage medium comprising program instructions executable by the processor for terminating operation of the cold plasma generator after a set time period subsequent to terminating operation of the nebulizer.
Claims
1. A disinfection device, comprising: an enclosure comprising an interior cavity; a closable loading port for providing access to the interior cavity; a chamber distinct from the interior cavity and having an air inlet and air outlet respectively coupled to an outlet and an inlet of the interior cavity for providing airflow between the chamber and the interior cavity; a cold plasma generator disposed in the chamber; a fan arranged within or in proximity to the outlet of the interior chamber such that air from the interior cavity is forced through the air inlet of the chamber and routed to the cold plasma generator; and a nebulizer, wherein the cold plasma generator, the fan, and the nebulizer are arranged in the disinfection device such that: plasma species generated by the cold plasma generator are routed to an area to which droplets formed by the nebulizer are discharged; and the interior cavity is exposed to a mixture of the droplets and the plasma species.
2. The disinfection device of claim 1, wherein the nebulizer is arranged in the chamber downstream from the cold plasma generator.
3. The disinfection device of claim 1, wherein the nebulizer is arranged in the interior cavity.
4. The disinfection device of claim 3, wherein the nebulizer is arranged within 12 inches of the air outlet of the chamber and such that a nozzle of the nebulizer discharges droplets toward an area in the interior cavity adjacent the air outlet of the chamber.
5. The disinfection device of claim 1, further comprising an additional chamber distinct from the interior cavity, wherein the nebulizer is arranged in the additional chamber, and wherein the additional chamber comprises a fluid outlet for passing droplets formed by the nebulizer into the interior cavity.
6. The disinfection device of claim 5, wherein the air outlet of the chamber in which the cold plasma generator is arranged and the fluid outlet of the additional chamber are configured in the disinfection device to direct their discharge to a common area in the interior cavity which is within approximately 12 inches of each of the air outlet and the fluid outlet.
7. The disinfection device of claim 1, wherein the nebulizer is configured and arranged in the disinfection device such that droplets having a diameter of 10 microns or greater are discharged into the interior cavity.
8. The disinfection device of claim 1, further comprising an electronic control system comprising a processor and a storage medium comprising program instructions executable by the processor for: activating the fan; activating the cold plasma generator; activating the nebulizer; terminating operation of the nebulizer; and terminating operation of the cold plasma generator after a set time period subsequent to terminating operation of the nebulizer.
9. A disinfection device, comprising: an enclosure comprising an interior cavity; a closable loading port for providing access to the interior cavity; a cold plasma generator, wherein the disinfection device is configured such that plasma species generated by the cold plasma generator are discharged in the interior cavity; a nebulizer, wherein the disinfection device is configured such that droplets generated by the nebulizer are discharged in the interior cavity; a fan arranged in the disinfection device to move air, the plasma species and the droplets in the disinfection device; and an electronic control system comprising a processor and a storage medium comprising program instructions executable by the processor for: activating the fan; activating the cold plasma generator; activating the nebulizer; terminating operation of the nebulizer; and terminating operation of the cold plasma generator after a set time period subsequent to terminating operation of the nebulizer.
10. The disinfection device of claim 9, wherein the set time period is between approximately 5 minutes and approximately 15 minutes.
11. The disinfection device of claim 9, wherein the program instructions for terminating the operation of the nebulizer comprises terminating the operation of the nebulizer while maintaining operation of the fan and the cold plasma generator.
12. The disinfection device of claim 9, wherein the storage medium further comprises program instructions executable by the processor for: terminating operation of the cold plasma generator prior to or at the same time as the step of terminating operation of the nebulizer; reactivating the cold plasma generator, wherein the step of terminating operation of the cold plasma generator after a set time period subsequent to terminating operation of the nebulizer comprises terminating operation of the reactivated cold plasma generator; and maintaining operation of the fan between the steps of terminating operation and reactivating the cold plasma generator.
13. The disinfection device of claim 9, further comprising a heating element arranged in the disinfection device to heat the interior cavity, wherein the storage medium further comprises program instructions executable by the processor for activating the heating element at the same time or subsequent to the step of terminating operation of the cold plasma generator.
14. The disinfection device of claim 9, wherein the program instructions for activating the fan comprise program instructions for activating the fan to operate at a flow rate of at least 0.3 m.sup.3 per minute.
15. A disinfection device, comprising: an enclosure comprising an interior cavity; a closable loading port for providing access to the interior cavity; a chamber distinct from the interior cavity and having an air inlet and air outlet respectively coupled to an outlet and an inlet of the interior cavity for providing airflow between the chamber and the interior cavity; a cold plasma generator disposed in the chamber; a fan arranged within or in proximity to the outlet of the interior chamber such that air from the interior cavity is forced through the air inlet of the chamber and routed to the cold plasma generator and that plasma species generated by the cold plasma generator are discharged into the interior cavity; a nebulizer arranged in the disinfection device such that droplets formed by the nebulizer are discharged in the interior cavity; and a heating element to heat the interior cavity.
16. The disinfection device of claim 15, wherein the heating element and the disinfection device are configured to raise and maintain a temperature in the interior cavity to be between approximately 40° C. and approximately 60° C. for a predetermined amount of time.
17. The disinfection device of claim 16, further comprising an electronic control system comprising a processor and a storage medium, wherein the storage medium comprises program instructions executable by the processor for: activating the cold plasma generator; terminating operation of the cold plasma generator; and activating the heating element at the same time or subsequent to the step of terminating operation of the cold plasma generator.
18. The disinfection device of claim 17, wherein the storage medium further comprises program instructions executable by the processor for: activating the nebulizer; and terminating operation of the nebulizer prior to the step of terminating the cold plasma generator.
19. The disinfection device of claim 15, wherein the nebulizer is configured to generate microdroplets having a mean diameter of approximately 5 μm or less.
20. The disinfection device of claim 15, wherein the interior cavity comprises a volume between approximately 0.1 liters and approximately 100 liters.
Description
BRIEF DESCRIPTION OF THE FIGURES
[0012] Other objects and advantages of the invention will become apparent upon reading the following detailed description and upon reference to the accompanying drawings in which:
[0013]
[0014]
[0015]
[0016]
[0017]
[0018]
[0019]
[0020] While the invention is susceptible to various modifications and alternative forms, specific embodiments thereof are shown by way of example in the drawings and will herein be described in detail. It should be understood, however, that the drawings and detailed description thereto are not intended to limit the invention to the particular form disclosed, but on the contrary, the intention is to cover all modifications, equivalents and alternatives falling within the spirit and scope of the present invention as defined by the appended claims.
DETAILED DESCRIPTION OF THE INVENTION
[0021] Disinfection devices disclosed herein generate cold plasma-generated reactive oxygen and nitrogen species (RONS) to disinfect items. Although cold plasma technology has been experimented with to decontaminate produce, such processes have been limited to makeshift systems without consideration of efficiency, costs, ease of use, or longevity of the system components. The disinfection devices disclosed herein, however, include several features and designs taking such factors into consideration, particularly for but not limited to disinfection devices having all components incorporated into single unit. For instance, as explained in more detail below, the disinfection devices disclosed herein are designed to generate droplets having dissolved reactive species without shorting the electrodes of the cold plasma generator despite the limited confines of the device in which the droplets are formed and circulated. In addition, the disinfection devices disclosed herein are designed to enable and emphasize the fissure of water droplets to achieve greater germicidal efficacy in a shorter amount of time. Furthermore, the disinfection devices disclosed herein are designed with components which are more economical and readily available than what was used in previous devices using cold plasma technology to disinfect produce. Moreover, the disinfection devices disclosed herein are designed to reduce the cycle time by which items may be retrieved relative to previous devices using cold plasma technology to disinfect produce.
[0022] As set forth in more detail below, each of the disinfection devices disclosed herein which include an enclosure comprising an interior cavity, a closable loading port for providing access to the interior cavity, a cold plasma generator, a fan, a nebulizer, a fluid supply, and optionally a heating element to heat the interior cavity. The arrangement of the components may vary as discussed in more detail below in reference to
[0023] As noted above, each of the disinfection devices disclosed herein include a cold plasma generator. The term “cold plasma” as used herein refers to a plasma which is not in thermodynamic equilibrium, particularly that the temperature of the electrons is much higher than the temperature of ions and neutrals. The term “cold plasma” as used herein is synonymous with the terms “non-thermal plasma” and “non-equilibrium plasma”. The cold plasma generators of the disinfection devices disclosed herein may include any generator known to generate a cold plasma. Examples of cold plasma generators which may be used for the disinfection devices disclosed herein include but are not limited to glow discharge, corona discharge, atmospheric pressure plasma jet, dielectric barrier discharge, micro-hollow cathode discharge, plasma needle, and low-pressure plasma. Furthermore, the cold plasma generators considered for the disinfection devices disclosed therein may include pulsed cold plasma generators or continuous wave cold plasma generators.
[0024] Both pulsed and continuous-wave dielectric barrier discharge cold plasma generators were used in the development of the disinfection devices disclosed herein and are known to function particularly well with the design considerations discussed herein. Advantages of dielectric barrier discharge cold plasma generators is small size, making them easily configured, and deployed into an enclosure. Continuous wave dielectric barrier discharge cold plasma generators are advantageous due to their availability and lower costs as compared to pulsed dielectric barrier discharge cold plasma generators. Yet, a disadvantage of employing continuous wave dielectric barrier discharge cold plasma generators is that they generate considerably more ozone in a given disinfection process as compared to pulsed dielectric barrier discharge cold plasma generators. The disinfection devices disclosed herein, however, are designed to remove the ozone prior to the end of a disinfection cycle as described in more detail below in reference to
[0025] Each of the disinfection devices disclosed herein also include a nebulizer. While any type of nebulizer may be used in the disinfection devices disclosed herein, it preferable to utilize a nebulizer that is configured to generate droplets having an average diameter of 5 μm or smaller. (The size of the microdroplets follows a bell curve on the size distribution, and thus there is variance in the size of the microdroplets.) In particular, small droplets not only allow for saturation of the interior cavity of the disinfection device in which the items are being disinfected but also increases the rate of transmission of the RONS species into the droplets because of the high surface area of the droplets. Thus, the smaller particle sizes are significantly more effective at reducing viral or bacterial loads as compared to larger fluid droplets.
[0026] A further component of the disinfection devices disclosed herein is a fluid supply line coupled to the nebulizer. In some cases, a disinfection device may include a refillable container coupled to the supply line for a user to supply fluid to prior to a disinfection process. Alternatively, a disinfection device may be configured to receive pre-filled containers of fluid at the supply line. In yet other cases, the disinfection device may be configured for attachment to a piped fluid line provided in an area or room in which the disinfection device is to be used. In some cases, a disinfection device may include multiple fluid supply containers and/or multiple fluid lines, each having a supply of a different fluid, such as water and various additional excipients. In such cases, a user may be able to configure a particular fluid mixture for a disinfection process. In addition or alternatively, a user interface of the disinfection device may offer different modes for disinfection, wherein one or more of the disinfection modes are associated with a different fluid make-up and the disinfection device is programmed to supply the appropriate fluid make-up for a selected disinfection mode. The different disinfection modes and, thus, the different fluid make-ups may be dependent on a number of variables, including but not limited to the type of object/s to be disinfected and/or a microorganism/s to be targeted during the disinfection process.
[0027] In general, the fluid fed to the nebulizer during a disinfection process includes water and, in some cases, it may further comprise additional excipients such as: acids, bases, buffer solutions (comprising a conjugate acid and base), peroxide solutions, bleach, peracetic acid, etc. The percentage of the additional excipients may vary depending on the application of the disinfection process, particularly the material, configuration, size, shape, or number of items to be disinfected and/or the microorganism/s to be targeted during the disinfection process. A collective concentration of one or more excipients in a fluid fed to the nebulizer may generally vary between 0.01% to approximately 20%. In yet other embodiments, the fluid to be atomized for the disinfection process may consist essentially of water. Thus, the amount of water in the fluid supply for a disinfection process may vary between approximately 80% and 100%. The water in the fluid may be tap water, deionized water, reverse osmosis deionized water, or purified water. For some disinfection processes, tap water may be advantageous since it contains minerals and dissolved solids including metallic ions which are useful in protecting the reactive species generated in plasma.
[0028] Turning to the drawings,
[0029] As shown in
[0030] In order for user interface 22 to affect the operation of disinfection device 10 and further convey information regarding its status and operation, disinfection device 10 includes a programmable microcontroller device, such as but not limited to an Arduino controller. In other words, disinfection device 10 includes a storage medium having processor and program instructions executable by the processor to affect operations of the device. More specifically, the microcontroller is in electrical communication (wired or wireless) with components of disinfection device 10 to affect and control their operation. For example, the controller may include program instructions to turn on and off certain components of disinfection device 10 in a particular sequence. More specifically, the controller is connected electronically to fluid supply 26, heating element 40, nebulizer 38, dielectric barrier discharge 36, and fan 34. Examples of program instructions for affecting operation of the disinfection devices disclosed herein are described in more detail in reference to
[0031] The term “program instructions”, as used herein, refers to commands within software which are configured to perform a particular function, such as but not limited to one or more of the processes described in reference to
[0032] As shown in
[0033] Disinfection device 10 further includes fluid supply container 18 arranged along an exterior side surface of the device. Such a position or arrangement along any other exterior surface of disinfection device 10 permits ready access to the container regardless of whether door 16 is open or closed. In alternative embodiments, fluid supply container 26 may be disposed inside disinfection device 10. In some of such cases, fluid supply container 26 may be disposed in interior cavity 14 such that a user has access to the container upon opening door 16. In yet other embodiments, fluid supply container 26 may be disposed in a chamber of disinfection device 10 separate from interior cavity 14. In such cases, disinfection device 10 may include a supply port along its exterior or within interior cavity 14 that allows a user to supply fluid to the container. In addition or alternatively, disinfection device 10 may include a separate door (i.e., distinct from door 16) along its exterior surface, which provides access to the fluid supply container, particularly to supply fluid thereto and/or to remove the container. In any case, disinfection device 10 includes a fluid line extending from the fluid supply 26 and terminates at a nebulizer within the device, such as shown by fluid line 28 in
[0034] Turning to
[0035] As shown in
[0036] Because air contains oxygen, nitrogen, and hydrogen, reactive oxygen and nitrogen species (RONS), such as but not limited to ozone (O.sub.3), hydroxyl radical (OH), hydrogen peroxide (H.sub.2O.sub.2), singlet oxygen (O.sub.2*), and/or peroxynitrite radical (ONOO*) are generated in the plasma. The RONS, most specifically the ozone, peroxides, and peroxynitrite, are strong oxidizing species and, thus, provide dramatic disinfection, particularly log reductions of pathogens, including bacteria, viruses, and spores. However, RONS are typically unstable. Accordingly, there is a need to stabilize the reactive species so that they can then attack pathogenic materials. In the disinfection devices disclosed herein, RONS are stabilized by dissolving them into droplets discharged from nebulizer. To affect such a mixture in disinfection device 10, nebulizer 38 is positioned downstream from dielectric barrier discharge 36 to accept and atomize fluid from the fluid line 28 as shown in
[0037] As set forth above, when fluid is expressed from a nebulizer of a disinfection device disclosed herein, it creates very small and fine droplets, specifically having an average diameter of 5 μm or smaller. The size of the droplets follows a bell curve of size distribution and, thus, there is variance in the size of the droplets. The small size of these droplets increases the rate of transmission of the RONS species into the microdroplets because of the high amount of surface area among the many droplets relative to if larger droplets are formed. Furthermore, once generated, the greater surface area and sheer number of droplets ensures that the droplets having dissolved RONS are in sufficient quantities and density to saturate the surface of the objects being disinfected in interior cavity 14.
[0038] As shown in
[0039] In some cases, the arrangements of fan 34 and/or the arrangement of one or other fans in disinfection device 10 may be to affect a particular flow path pattern in interior cavity 14, such as but not limited to the flow path indicated by arrows 39 in
[0040] In order to prevent droplets having a diameter of greater than 10 μm from entering the cold plasma generators of the disinfection devices disclosed herein, the disinfection devices are designed to route droplets generated from their nebulizers along a path and at a speed through their interior cavities which provides time for droplets having a diameter of greater than 10 μm to fall out of suspension in the air flow by gravity and/or to smash into the interior walls, ceiling and/or flooring before entering the cold plasma generator. Part of such a design is the arrangement of one or more fans in the disinfection devices to affect a particular flow path pattern and air flow speed in their interior cavities. Another part of such a design is the relative placement of the nebulizer and the cold plasma generator. In particular, it is advantageous to enable a flow path of approximately 1 meter or more between the output of the nebulizer and the inlet of the cold plasma generator. In general, the arrangement of the one or more fans, nebulizer, and cold plasma generator in a disinfection device to affect such an objective will depend on the size of its interior cavity.
[0041] In some cases, it may be advantageous to arrange the nebulizer and the cold plasma generator along the same sidewall of the disinfection device or both along the ceiling or flooring of the disinfection device, or even in relation to the same corner of the disinfection device, to maximize the potential length of a flow path through the interior cavity of the disinfection device, such as generally shown by arrows 39 in
[0042] In some cases, the cold plasma generator, the fan, and the nebulizer may be arranged in a disinfection device such that plasma species generated by the cold plasma generator are routed to an area to which droplets formed by the nebulizer are discharged. Disinfection device 10 depicted in
[0043] As noted above, the disinfection devices disclosed herein may, in some cases, include a heating element to heat the interior cavity, particularly to dry objects in the interior cavity which have been exposed to the droplets discharge from the nebulizer and further to destroy ozone generated by the cold plasma generator during the disinfection process. Disinfection device 10 in
[0044] As described in more detail below, in embodiments in which a disinfection device disclosed herein includes a heating element, the disinfection device may be configured to heat its interior cavity to a temperature between approximately 40° C. and approximately 60° C., in some embodiments, to a temperature of approximately 50° C. In some cases, a disinfection device disclosed herein may include a temperature sensor in its interior cavity, which sends signals to the microcontroller to control the temperature of the heating element to ensure a 50° C.±2° C. temperature is reached and maintained in the interior cavity during a heating cycle. In other cases, the heating element may be a coil style heater applying a known load, which is calibrated based on the airflow and space to reach the noted temperature ranges. As such, in such cases, an on/off cycle of the heating element may not be needed to reach and maintain the noted temperature ranges. However, to the extent that control is desired, the temperature probe can be utilized by the microcontroller to activate or deactivate the heating element or the fan to modify the temperature.
[0045] Given the aforementioned description of disinfection device 10 in
[0046] As noted above,
[0047] As shown in
[0048] Disinfection device 50 further differs from disinfection device 10 with nebulizer 38 arranged in interior cavity 14 and being arranged along a different sidewall surface than chamber 52. Such features are not mutually exclusive. In particular, chamber 52 could be extended to encase nebulizer 38 with opening 56 moved to the bottom of the chamber such that a mixture of RONS and droplets could be discharged into interior cavity 14. In yet other cases, nebulizer 14 could be alternatively arranged along the ceiling of disinfection device 50 discharging droplets downward to area 58. Such an arrangement may be advantageous for aligning the flow of droplets with airflow pattern indicated by arrows 59. In particular, discharging the droplets downward rather than toward opening 56 of chamber 52 may aid in preventing droplets larger than 10 μm from entering the chamber and potentially shorting dielectric barrier discharge 36. In other cases, however, the airflow through chamber 52 as governed by fan 34 may be sufficient to prevent such large droplets from entering opening 56 and, thus, the direction of discharge from nebulizer may not be of concern.
[0049] In any case, nebulizer 38 is spaced a sufficient distance from opening 56 to prevent such large droplets from entering the opening. However, such an objective should be balanced with the objective to route the RONS discharged from dielectric barrier discharge 36 to the area at which a high concentration of droplets from nebulizer 38 are discharged (depicted as area 58 in
[0050] As further shown in
[0051] Turning to
[0052] Disinfection device 60 further includes channel 65 extending from opening 66 of chamber 62. As shown, channel 65 is configured such that plasma species generated by dielectric barrier discharge 36 and discharged from opening 66 are routed to area 68 to which droplets formed by the nebulizer are discharged. In this manner, channel 65 and opening 63 are configured to direct their discharge to common area in interior cavity 14. The arrangement of channel 65 and chamber 67 may generally be such that the outlet of channel 65 and opening 63 of chamber 67 are in relatively close proximity, particularly to optimize the concentration of RONS routed to an area having a high concentration of droplets to facilitate the dissolving of RONS into the droplets. For example, the outlet of channel 65 and opening 63 of chamber 67 may be within approximately 12 inches of each other and, more specifically, within approximately 6 inches of each other.
[0053] Disinfection device 60 differs from disinfection devices 10 and 30 in that it includes separate chambers to house dielectric barrier discharge 36 and nebulizer 38 and the chambers are arranged exterior to enclosure 12. Such features are not mutually exclusive. In particular, the depiction of disinfection device 60 in
[0054] Disinfection device 60 further differs from disinfection devices 10 and 30 by the inclusion of a channel to route plasma species generated by dielectric barrier discharge 36 to an area at which droplets formed by the nebulizer are discharged. Such an element is not mutually exclusive to scenarios in which dielectric barrier discharge 36 and nebulizer 38 are housed in different chambers of the disinfection device. In particular, any of the disinfection devices disclosed herein may include a channel arranged in proximity to an outlet of a cold plasma generator to route plasma species to an area at which droplets formed by a nebulizer are discharged. Another distinction of disinfection device 60 from disinfection devices 10 and 30 is the omission of a heating element. As noted above, a heating element is an optional feature for the disinfection devices disclosed herein. Although it may be advantageous to utilize a heating element to dry objects in interior cavity as well as destroy ozone and other RONS in interior cavity 14 after a disinfection process is complete, such a process is not mandatory as ozone and other RONS will innately decompose on their own in time and the amount of residual moisture in the disinfection device after a disinfection process is complete is minimal. In any case, similar to disinfection device 50, disinfection device 60 may include fan 57 arranged to facilitate, along with fan 34, the airflow pattern depicted by arrows 69 in
[0055] As noted above,
[0056] It is noted that the disinfection devices disclosed herein are not limited to having nebulizer 38 disposed in interior cavity 14 when dielectric barrier discharge 36 is arranged in interior cavity 14. In particular, the disinfection devices disclosed herein may have nebulizer disposed in a chamber separate from interior cavity with dielectric barrier discharge 36 arranged in interior cavity 14.
[0057] Turning to
[0058] The one or more objects may include any objects in need of disinfection, and which can fit in the interior cavity of the disinfection device, which will vary among units. Objects which may be disinfected by the disinfection devices disclosed herein include but are not limited to personal protective equipment (PPE), such as but not limited to masks, gowns, face shields, and goggles, including PPE designed for single use and those design for multiple uses. Other objects which may be considered and are often found in a healthcare setting are stethoscopes, blood pressure cuffs, television remotes, and medical supplies intended for single use or multiple uses, such as but not limited to alcohol wipes, bandages, and gloves. Several other objects may be considered and are not limited to objects typically found in a healthcare setting. Other settings which often include objects in need of disinfection include personal care environments, clean rooms, food manufacturing and/or processing plants, food handling establishments, pharmaceutical laboratories and plants, childcare facilities, animal care centers, and agricultural buildings.
[0059] In any case, the method for disinfecting the objects include supplying fluid to the disinfection as denoted in block 82 in
[0060] As shown in block 84, the interior cavity is closed and a disinfection process is activated subsequent to inserting one or more objects into the interior cavity of the disinfection device. Once a disinfection process is activated, the door is locked and the disinfection device is activated to perform a check on the electronic components of the device. The system uses several different sensors to confirm proper operation of the multiple components in the disinfection device before beginning a disinfection cycle, including but not limited to checking the one or more fans in the unit, confirming operation of the cold plasma generator, and confirming sufficient fluid level in addition to the door check. The fans can utilize sensors on the fans themselves or the electrical resistance to confirm their operation. The operation of the cold plasma generator may utilize a sensor to validate the presence of ozone or plasma, thus indicating operation. For example, an inline ozone sensor, or a UV sensor (to confirm light emission) can be utilized to confirm operation. The microcontroller of the disinfection device, being electrically connected to each of the devices or sensors, performs the appropriate check and indicates success or failure of the elements on the control panel via the information conveying devices. As shown in block 86 of
[0061] Turning to block 90 of
[0062] As shown in block 94 of
[0063] The temperature range specified above for heating cycle denoted in block 96 is utilized to destroy the residual chemistries including the ozone and other reactive species within the interior cavity of the disinfection device. In particular, the heat cycle destroys the reactive species so that when the door is opened, reactive species are not introduced into the ambient air. Thus, there is no need for a BSL (biosafety level)-2 or -3 condition for operation of the device. The heating cycle may be particularly beneficial if a continuous-wave dielectric barrier discharge is employed in the disinfection device. In particular, such a cold plasma generator can generate in excess of 7,000 ppm ozone in the interior chamber during a given disinfection cycle. A second benefit of a heating cycle is that it reduces the moisture content in the interior cavity of the disinfection device to allow the one or more objects therein to dry. A benefit of the specified temperature range is that it is sufficiently low to limit damage to the one or more objects in the disinfection device, particularly objects which are intended for single use since they are typically made of materials which are not intended to be exposed to harsh elements, such as high temperatures. It is noted that the microdroplet generation cycle utilizes a very small amount of water (˜1 mL for some cycles) and, thus, the moisture content is not high after a disinfection cycle is completed. Because of that, the low specified temperature during the heating cycle is sufficient to dry the one or more objects placed in the disinfection device. During the heating cycle, one or more fans operate to elevate and maintain the temperature in the interior cavity of the disinfection device in a relatively uniform manner.
[0064] In some cases, the time frame of the disinfection protocol involving blocks 90 and 92 and optionally blocks 94 and 96 may generally be between approximately 20 minutes and approximately 45 minutes, and more preferably between approximately 20 and approximately 35 minutes. Several protocols were tested with varying reductions of viral loads and which are detailed in the examples and tables below. An example cycle time for creating a mixture of plasma and microdroplets denoted in block 90 may be between 5 minutes and approximately 15 minutes. An example cycle time for generating plasma without droplet formation denoted in block 92 may be between approximately 5 minutes and approximately 15 minutes. An example cycle time for the heating cycle denoted in block 96, if employed, may be between approximately 10 minutes and approximately 20 minutes. An example cycle time for the dwell time cycle denoted in block 94, if employed, may be between approximately 10 minutes and approximately 20 minutes.
[0065] Turning to
[0066] As shown in block 110, the disinfection devices disclosed herein may include program instructions for terminating operation of the nebulizer after activating each of the components noted in blocks 102, 104 and 106, particularly after a set amount of time. In some cases, the disinfection device disclosed herein may include program instructions for a dwell time cycle after a mixture of plasma species and droplets are created as described in reference to blocks 90 and 94 of
[0067] In addition, the disinfection devices disclosed herein include program instructions for terminating operation of the cold plasma generator after the time as elapsed as denoted in block 116 of
EXAMPLES
[0068] Diameters of the microdroplets were measured using a laser diffraction droplet size analyzer (Malvern Instruments, USA). The analyzer operated at 10 kHz and averaged an output of 10,000 measurements per second using a 5 mW He—Ne laser, 10 mm diameter, with a Fourier lens and a detector array to capture the diffracted light. Based on testing, the average particle size generated under this system was 5 microns, which shows significant improvements over particles at 50 microns in size because of increased surface area.
[0069] A disinfection chamber having a configuration similar to disinfection device 10 in
[0070] To test the validity of the system, petri dishes with E. coli were placed on shelves within the chamber. Ozone measurements were taken via electric ozone sensors as well as paper strips, and additional tests, using paper strips, tested hydrogen peroxide, NO.sub.3, and NO.sub.2 within the fluid droplets.
[0071] Our samples showed that using the protocol of 10 minutes of plasma, 5 minutes of nebulization of fluid, followed by 10 minutes of 50° C. air recirculation we reached >6-log reduction of the bacteria on all materials and surfaces and >3-log reduction of virus.
TABLE-US-00001 TABLE 1 Results E. Coli Listeria Salmonella B. Cereus 25 SLPM 4-log 4-log 4-log 4-log 50 SLPM 8-log 8-log 8-log 8-log 75 SLPM 8-log 8-log 8-log 8-log
[0072] Accordingly, using a fan that generates approximately 0.3 m3 (300 SLPM) airflow per minute, we were able to maximize the log reduction of the bacterial loads. This optimizes the flow of air over the dielectric barrier discharge and the intermixing with the nebulized microdroplets to create the optimized RONS for antimicrobial activity.
[0073] Using the five-micron-sized microdroplets resulted in a >8-log reduction of E. coli, Listeria, Salmonella, and B. cereus on various surfaces, as well as B. cereus spore inactivation. On the fabric surface of a material similar to N95 respirator masks, a >3-log reduction of MS2 phage (nonenveloped virus) was observed. We utilized this virus as a reasonable viral sample that is difficult to kill than enveloped viruses. We also tested Phi6, which serves as a surrogate for COVID-like viruses. The FDA recommends that the viricidal activity is a >3-log reduction, and our studies showed that these levels were reached by the final protocol.
[0074] At 25 SLPM we found a 2-log reduction for all viruses, and at 50 and 75 SLPM we found a 3-log reduction for all viruses.
[0075] Interestingly, we also tested another protocol, which was 5 minutes of plasma nebulizer activation followed by 5 minutes of dwell time and finally 10 minutes of dry cycle at 50° C. This resulted in a 2-log reduction on plates, and a 1-log reduction on PPE. Accordingly, the time for plasma generation is important to ensure sufficient concentrations of reactive species within the cleaning chamber. We also tested 15 minutes of plasma, 5 minutes of nebulizer, and 10 minutes of nebulizer, and this resulted in the same kill rates as the 10 minutes of plasma and 5 minutes of nebulizer. The goal is to have the lowest total cycle time while reaching the necessary kill rate.
[0076] We also tested the impacts of heat on the product with regard to time and chemistry. While temperatures above 40° C. were sufficient to destroy the radical chemistries, the drying and damage results varied widely. The following were observed with regard to temperature and time for the heat cycle. Using a 10-minute heat cycle, heat at 40° C. resulted in wet PPE, 45° C. also resulted in wet materials. At 50° C. the materials were dry, at 55° C., 60° C., and 75° C., the material was also dry in 10 minutes. However, we noticed some deformation of the materials at temperatures of 75° C., and the temperatures of 55C° and 60° C. were not necessary to improve the drying or the destruction of the radical chemistries. Accordingly, 50° C. was advantageous to meet all of the goals of destroying reactive species and drying the materials efficiently and safely.
[0077] We also tested a longer heating cycle of 20 minutes. At 20 minutes, the 40° C. remained slightly damp, while at 45° C. it was dry. However, the longer time made the entire protocol take longer than using 50° C. Accordingly, 50° C. ±2° C. appears to be an optimized value.
Use of Di Water, RO-DI Water, and Tap Water
[0078] We tested whether the fluid source would impact the kill rates. Here the three different samples yielded surprisingly different results. While tap water yielded the 8-log reductions, use of DI and RO-DI water in identical run cycles reduced yield to 5-log in each case. Surprisingly, the inclusion of small amounts of metals, dissolved salts, and such improved the kill rate on the tested plates.
[0079] The materials tested and expected for common use in the devices includes the following listed in Table 2 below.
TABLE-US-00002 TABLE 2 What is being measured On what surface Log Reduction E. coli inactivation Agarose gel 4 E. coli inactivation Mask fabrics 3 E. coli inactivation Face Shields Plastics 5 Pseudomonas syringae inactivation Agarose gel 4 Pseudomonas syringae inactivation Mask fabrics 3 Pseudomonas syringae inactivation Face Shields Plastics 5 Bacillus subtilis inactivation Agarose gel 3 Bacillus subtilis inactivation Mask fabrics 2 Bacillus subtilis inactivation Face Shields Plastics 4 Aspergillus niger inactivation Agarose gel 3 Aspergillus niger inactivation Mask fabrics 2 Aspergillus niger inactivation Face Shields Plastics 4 MS2 phage (virus) inactivation Mask fabrics 3 MS2 phage (virus) inactivation Face Shields Plastics 4 Phi6 phage (virus) inactivation Mask fabrics 3 Phi6 phage (virus) inactivation Face Shields Plastics 4 PhiX174 phage (virus) inactivation Mask fabrics 3 PhiX174 phage (virus) inactivation Face Shields Plastics 4 PM2 phage (virus) inactivation Mask fabrics 3 PM2 phage (virus) inactivation Face Shields Plastics 4 Human influenza A virus H1N1 inactivation Mask fabrics 3 4Human influenza A virus H1N1 inactivation Face Shields Plastics 4 Newcastle disease virus inactivation Mask fabrics 3 Newcastle disease virus inactivation Face Shields Plastics 4 SARS-CoV-2 inactivation Mask fabrics 3 SARS-CoV-2 inactivation Face Shields Plastics 4
[0080] Accordingly, from all our studies we tested the following parameters, and identified the optimized protocol to meet the necessary log reductions, having a short cleaning cycle, ensuring dry products, and reducing damage to the PPE. Study parameters are listed below.
TABLE-US-00003 TABLE 3 Highest log inactivation Parameter Range studied achieved at Plasma on time 3-15 minutes 10 minutes Plasma fan speed 0.1-0.5 m3/min 0.3 m3/min Nebulizer on time 1-15 minutes 5 minutes Nebulization flow rate 0.05-0.5 mL/min 0.2 mL/min 50° C. heat + fan time 5-20 minutes 10 minutes
[0081] Therefore, an optimized protocol uses a 10-minute plasma cycle with a fan speed of 0.3 m3/min. The nebulizer is running for the first 5 minutes of the plasma cycle at 0.2 mL/min of fluid, and finally a 10-minute dry cycle. This protocol optimized results by increasing kill rate and reducing run time and wear and tear on the PPE.
[0082] It will be appreciated to those skilled in the art having the benefit of this disclosure that this invention is believed to provide disinfection devices that do not cause damage to items being disinfected, sufficiently access all surfaces of items being disinfected in a relatively short amount of time and are economical. Further modifications and alternative embodiments of various aspects of the invention will be apparent to those skilled in the art in view of this description. Accordingly, this description is to be construed as illustrative only and is for the purpose of teaching those skilled in the art the general manner of carrying out the invention. It is to be understood that the forms of the invention shown and described herein are to be taken as the presently preferred embodiments. Elements and materials may be substituted for those illustrated and described herein, parts and processes may be reversed, and certain features of the invention may be utilized independently, all as would be apparent to one skilled in the art after having the benefit of this description of the invention. Changes may be made in the elements described herein without departing from the spirit and scope of the invention as described in the following claims. The term “approximately” as used herein refers to variations of up to +/−5% of the stated number.